JP2022527556A5 - - Google Patents
Info
- Publication number
- JP2022527556A5 JP2022527556A5 JP2021559254A JP2021559254A JP2022527556A5 JP 2022527556 A5 JP2022527556 A5 JP 2022527556A5 JP 2021559254 A JP2021559254 A JP 2021559254A JP 2021559254 A JP2021559254 A JP 2021559254A JP 2022527556 A5 JP2022527556 A5 JP 2022527556A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- product according
- pharmaceutical product
- phenyl
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962830019P | 2019-04-05 | 2019-04-05 | |
| US62/830,019 | 2019-04-05 | ||
| PCT/US2020/026625 WO2020206289A1 (en) | 2019-04-05 | 2020-04-03 | Selective inhibitors of protein arginine methyltransferase 5 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527556A JP2022527556A (ja) | 2022-06-02 |
| JP2022527556A5 true JP2022527556A5 (cg-RX-API-DMAC7.html) | 2023-04-07 |
Family
ID=72666997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559254A Pending JP2022527556A (ja) | 2019-04-05 | 2020-04-03 | プロテインアルギニンメチルトランスフェラーゼ5の選択的阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220152072A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3952874A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022527556A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020206289A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11077101B1 (en) | 2018-07-18 | 2021-08-03 | Tango Therapeutics, Inc. | Compounds and methods of use |
| US12403137B2 (en) | 2019-10-28 | 2025-09-02 | Tango Therapeutics, Inc. | Compounds and methods of use |
| CN116568677B (zh) | 2020-07-31 | 2026-07-28 | 探戈医药股份有限公司 | 可用于治疗mtap缺乏和/或mta累积癌症的哌啶-1-基-n-吡啶-3-基-2-氧代乙酰胺衍生物 |
| CN117062816A (zh) * | 2021-02-04 | 2023-11-14 | 美国安进公司 | 三环-酰胺-双环prmt5抑制剂 |
| US20240262857A1 (en) * | 2021-05-27 | 2024-08-08 | Emory University | Novel universal anti-rna virus agents |
| CN113546173B (zh) * | 2021-08-19 | 2022-08-23 | 徐州医科大学 | Prmt5抑制剂在制备治疗冠状病毒感染所引起的疾病的药物中的应用 |
| WO2024012308A1 (zh) * | 2022-07-15 | 2024-01-18 | 上海和誉生物医药科技有限公司 | 一种prmt5抑制剂,其制备方法和在药学上的应用 |
| WO2024170488A1 (en) | 2023-02-13 | 2024-08-22 | Astrazeneca Ab | Prmt5 inhibitor for use in cancer therapy |
| EP4553080A1 (en) * | 2023-11-07 | 2025-05-14 | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. | Nucleoside derivatives as antiviral agents against coronaviruses |
| US20250313552A1 (en) * | 2024-04-04 | 2025-10-09 | New Frontier Bio, Inc. | Nicotinate esters and therapeutic methods of use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL108523A0 (en) * | 1993-02-03 | 1994-05-30 | Gensia Inc | Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain |
| US6495579B1 (en) * | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| HRP20090646T1 (hr) * | 2005-03-17 | 2010-01-31 | Proyecto De Biomedicina Cima | Uporaba 5'-metiltioadenozina (mta) kod prevencije i/ili liječenja autoimunih bolesti i/ili odbacivanje transplantata |
| WO2009089804A1 (en) * | 2008-01-18 | 2009-07-23 | Institute Of Organic Chemistry And Biochemistry As Cr, V.V.I. | Novel cytostatic 7-deazapurine nucleosides |
| WO2011075665A2 (en) * | 2009-12-18 | 2011-06-23 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| WO2015200680A2 (en) * | 2014-06-25 | 2015-12-30 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
| WO2016079321A1 (en) * | 2014-11-20 | 2016-05-26 | Cemm Forschungszentrum Für Molekulare Medizin Gmbh | Antagonists of setdb2 for use in the therapy of infectious diseases |
| TWI730980B (zh) * | 2015-08-26 | 2021-06-21 | 比利時商健生藥品公司 | 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物 |
| LT3399984T (lt) * | 2016-01-08 | 2023-11-10 | Arcus Biosciences, Inc. | 5'-nukleotidazės, ekto moduliatoriai ir jų panaudojimas |
| CN110325188A (zh) * | 2016-10-26 | 2019-10-11 | 印第安纳大学理事会 | 小分子蛋白质精氨酸甲基转移酶5(prmt5)抑制剂和治疗方法 |
| MA49840A (fr) * | 2017-08-09 | 2020-06-17 | Prelude Therapeutics Inc | Inhibiteurs sélectifs de la protéine arginine méthyltransférase 5 (prmt5) |
| WO2020033285A1 (en) * | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| EP3833667B1 (en) * | 2018-08-07 | 2024-03-13 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
-
2020
- 2020-04-03 WO PCT/US2020/026625 patent/WO2020206289A1/en not_active Ceased
- 2020-04-03 US US17/601,479 patent/US20220152072A1/en not_active Abandoned
- 2020-04-03 JP JP2021559254A patent/JP2022527556A/ja active Pending
- 2020-04-03 EP EP20783811.1A patent/EP3952874A4/en not_active Withdrawn